In the past week, CRBP stock has gone down by -7.99%, with a monthly decline of -25.62% and a quarterly plunge of -58.02%. The volatility ratio for the week is 7.31%, and the volatility levels for the last 30 days are 7.07% for Corbus Pharmaceuticals Holdings Inc The simple moving average for the past 20 days is -11.52% for CRBP’s stock, with a -78.11% simple moving average for the past 200 days.
Is It Worth Investing in Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Right Now?
Additionally, the 36-month beta value for CRBP is 3.04. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CRBP is 10.57M and currently, short sellers hold a 22.98% ratio of that float. The average trading volume of CRBP on March 19, 2025 was 254.14K shares.
CRBP) stock’s latest price update
The stock price of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) has plunged by -9.05 when compared to previous closing price of 6.96, but the company has seen a -7.99% decline in its stock price over the last five trading sessions. zacks.com reported 2025-03-13 that Corbus Pharmaceuticals (CRBP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
Analysts’ Opinion of CRBP
Wedbush gave a rating of “Outperform” to CRBP, setting the target price at $85 in the report published on July 30th of the previous year.
CRBP Trading at -31.97% from the 50-Day Moving Average
After a stumble in the market that brought CRBP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.77% of loss for the given period.
Volatility was left at 7.07%, however, over the last 30 days, the volatility rate increased by 7.31%, as shares sank -22.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -47.43% lower at present.
During the last 5 trading sessions, CRBP fell by -7.99%, which changed the moving average for the period of 200-days by -85.45% in comparison to the 20-day moving average, which settled at $7.15. In addition, Corbus Pharmaceuticals Holdings Inc saw -46.36% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRBP starting from Smethurst Dominic, who sale 6,393 shares at the price of $6.78 back on Mar 06 ’25. After this action, Smethurst Dominic now owns 70,807 shares of Corbus Pharmaceuticals Holdings Inc, valued at $43,330 using the latest closing price.
Smethurst Dominic, the Officer of Corbus Pharmaceuticals Holdings Inc, proposed sale 6,393 shares at $6.84 during a trade that took place back on Mar 06 ’25, which means that Smethurst Dominic is holding shares at $43,728 based on the most recent closing price.
Stock Fundamentals for CRBP
The total capital return value is set at -0.34. Equity return is now at value -59.34, with -43.67 for asset returns.
Based on Corbus Pharmaceuticals Holdings Inc (CRBP), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -12.9. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -40.26.
The liquidity ratio also appears to be rather interesting for investors as it stands at 12.94.
Conclusion
In conclusion, Corbus Pharmaceuticals Holdings Inc (CRBP) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
